TT, absolutely if we have more sales. But it’s somewhat confusing the strategy here. Some say sales are not the big thing but instead, the company is primed or “in play” for a takeover.
Which is it?
- Forums
- ASX - By Stock
- Ann: 200th patient treated with the OncoSil device
OSL
oncosil medical ltd
Add to My Watchlist
6.84%
!
$1.02

TT, absolutely if we have more sales. But it’s somewhat...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.065(6.84%) |
Mkt cap ! $14.43M |
Open | High | Low | Value | Volume |
$1.00 | $1.03 | 96.0¢ | $23.22K | 23.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15628 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 1042 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15628 | 0.950 |
2 | 1349 | 0.940 |
1 | 627 | 0.920 |
1 | 23 | 0.910 |
1 | 20000 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 1042 | 1 |
1.030 | 27 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
1.080 | 48 | 1 |
Last trade - 14.07pm 18/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online